Clinical Trial Detail

Clinical Trials

Clinical Trial Detail

Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

Complete title: AALL08B1, Classification of Newly Diagnosed Acute Lymphoblastic Leukemia (ALL).

Research Study Number AALL08B1
Principal Investigator Doug Hawkins, MD

Research Study Description

This research trial studies a risk-based classification system for patients with newly diagnosed acute lymphoblastic leukemia. Gathering health information about patients with acute lymphoblastic leukemia may help doctors learn more about the disease and plan the best treatment.

Eligibility Criteria (must meet the following to participate in this study)

** For Eligibility information, please click on the "Look up trial at NIH" link above. **

Other eligibility criteria may apply.

Research Study Number AALL08B1
Contact Lindsey Jackson
Telephone 206/884-7313

Keywords: Leukemia, Acute Lymphoblastic (ALL); Hematologic Malignancies; Leukemia; Lymphoproliferative Disorders; Pediatric Cancers, Miscellaneous; Leukemia, Lymphoid; Immunoproliferative Disorders; Leukemia, T-Cell, Acute Lymphoblastic; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Immune System Diseases; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.

Please remember:

  • Talk to your health care providers first before making decisions about your health care.
  • Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each study.

Subscribe to an RSS feed of all trials